Background Adherence to direct oral anticoagulants (DOACs) remains a concern among
non‐valvular atrial fibrillation (AF) patients. We aimed to assess patterns of adherence with …

Background The direct oral anticoagulants (DOACs) reduce the risk of stroke in moderate to
high-risk patients with non-valvular atrial fibrillation (AF). Yet, concerns remain regarding its …

Background: Stroke reduction with direct oral anticoagulants (DOACs) in atrial fibrillation
(AF) is dependent on adherence and persistence in the real-world setting. Individual study …

Background: Long-term treatment with direct oral anticoagulants (DOAC) is required for the
majority of patients with nonvalvular atrial fibrillation (AF) to prevent ischemic stroke and …

Background Direct oral anticoagulants (DOACs) are widely used in patients with nonvalvular
atrial fibrillation for stroke prevention. However, long‐term adherence to DOACs and clinical …

Abstract Purpose Direct oral anticoagulants (DOACs) have been promoted in patients with
nonvalvular atrial fibrillation (nv‐AF) as a more convenient alternative to vitamin K …

Few studies assessed the association between major adverse cardiovascular events and
adherence to warfarin and direct oral anticoagulants (DOACs) in patients with atrial …

Background For most patients with newly diagnosed atrial fibrillation (AF), direct oral
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …

Background Patients with atrial fibrillation (AF) are frequently nonadherent to oral
anticoagulants (OACs) prescribed for prevention of stroke and systemic embolism (SSE) …

Aims Direct oral anticoagulants (DOACs) are increasingly used for stroke prevention in atrial
fibrillation. However, little is known about the association between medication adherence …